18.25
Schlusskurs vom Vortag:
$18.57
Offen:
$18.5
24-Stunden-Volumen:
131.98K
Relative Volume:
0.39
Marktkapitalisierung:
$685.45M
Einnahmen:
$89.06M
Nettoeinkommen (Verlust:
$-53.41M
KGV:
-12.49
EPS:
-1.4612
Netto-Cashflow:
$-42.48M
1W Leistung:
+2.65%
1M Leistung:
+2.24%
6M Leistung:
+45.03%
1J Leistung:
-1.14%
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CBLL
Ceribell Inc
|
18.21 | 699.00M | 89.06M | -53.41M | -42.48M | -1.4612 |
|
ABT
Abbott Laboratories
|
102.04 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
331.89 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.23 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.50 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.02 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
CBLL Technical Analysis & Stock Price Forecast - Intellectia AI
CBLL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 11,112 Shares of Stock - MarketBeat
Raymond Woo, Ceribell CTO, sells $206k in CBLL stock - investing.com
Ceribell (CBLL) CEO awarded stock options and 97,555 RSUs - Stock Titan
Ceribell (CBLL) CFO receives stock options and RSU equity awards - Stock Titan
Ceribell (CBLL) finance chief receives stock options and 22,050 RSUs - Stock Titan
Ceribell (CBLL) CRO granted stock options and RSU awards - Stock Titan
Ceribell (CBLL) CTO exercises options, sells 11,112 shares and gets new grants - Stock Titan
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results - Insider Monkey
CBLL (NASDAQ: CBLL) Form 144 shows insider sales and option resales - Stock Titan
Protara, Ceribell rise on FDA breakthrough designations - MSN
Short Interest in CeriBell, Inc. (NASDAQ:CBLL) Declines By 13.8% - MarketBeat
CeriBell, Inc. (NASDAQ:CBLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Ceribell (CBLL) CEO exercises stock options, now holds 766,792 shares - stocktitan.net
Ceribell, Inc. honors Alex Purcell with Citizens Award for leadership in training initiatives - Traders Union
Buyback Watch: Is CeriBell Inc forming a breakout pattern2026 Trade Ideas & Real-Time Market Sentiment Reports - baoquankhu1.vn
ETF Watch: What are the risks of holding CeriBell Inc2026 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Ceribell, Inc. (CBLL) reports Q4 loss, beats revenue estimates - MSN
CeriBell, Inc. (NASDAQ:CBLL) Short Interest Update - MarketBeat
CBLL PE Ratio & Valuation, Is CBLL Overvalued - Intellectia AI
Suma receives Ceribell, Inc. accolade for breakthrough neonatal care innovation - Traders Union
Ceribell’s Woo sells $202k in shares - Investing.com Nigeria
Foehr David, senior VP at Ceribell, sells $81k in CBLL stock - Investing.com Nigeria
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium - Yahoo Finance
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot - Yahoo Finance
CBLL wins FDA breakthrough status for AI-based LVO stroke detection - MSN
Robertson sells Ceribell (CBLL) shares worth $14,720 By Investing.com - Investing.com India
CeriBell (NASDAQ:CBLL) CEO Sells $680,550.00 in Stock - MarketBeat
CeriBell (NASDAQ:CBLL) Director Rebecca Robertson Sells 827 Shares - MarketBeat
David Foehr Sells 4,560 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Robertson sells Ceribell (CBLL) shares worth $14,720 - Investing.com Nigeria
Ceribell CEO Chao sells $680k in CBLL stock By Investing.com - Investing.com Canada
Ceribell CEO Chao sells $680k in CBLL stock - Investing.com India
Ceribell Insider Sold Shares Worth $680,564, According to a Recent SEC Filing - marketscreener.com
Director at Ceribell (CBLL) sells 827 shares via Rule 10b5-1 plan - Stock Titan
Ceribell Earnings Call Highlights Strong Growth, Rising Costs - The Globe and Mail
Ceribell’s Woo sells $202k in shares By Investing.com - Investing.com Australia
CeriBell (NASDAQ:CBLL) CTO Sells $147,587.75 in Stock - MarketBeat
CBLL (NASDAQ: CBLL) affiliate Xingjuan Chao sells multiple blocks totaling 145,084 shares - Stock Titan
CBLL (NASDAQ: CBLL) Rule 144 notice; affiliate to sell 4,560 shares - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord - Insider Monkey
CBLL SEC FilingsCeriBell, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector - DirectorsTalk Interviews
CBLL Should I Buy - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and Option Care Health (OPCH) - The Globe and Mail
Earnings Call Summary | Ceribell(CBLL.US) Q4 2025 Earnings Conference - 富途牛牛
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ceribell Inc-Aktie (CBLL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Woo Raymond | Chief Technology Officer |
Apr 01 '26 |
Sale |
18.56 |
11,112 |
206,244 |
166,912 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):